Search
Telix Pharmaceuticals Ltd
TLXAdd to Watchlist
11.950USD
+0.640+5.66%
Close 09-22 16:00（ET）
0.00Market Cap
0.00P/E TTM
Pre-market 05:27 (ET)11.570USD-0.380-3.18%
Pre-market 05:27 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+5.66%
5 Days
-6.86%
1 Month
+5.47%
6 Months
+36.57%
Year to Date
+59.55%
1 Year
+18.91%
Key Figures
11.930Open
12.100High
50.58KVolume
0.00P/E TTM
0.00P/E Dynamic
--Dividend TTM
--Turnover Ratio
11.310Prev. Close
11.830Low
604.16KTurnover
0.00P/E Static
0.00P/B
0.00%Div Yield TTM
--ROA
13.11052wk High
30.94Volume Ratio
--Net Profit
--Shares
--EPS TTM
--Beta
--ROE
6.28052wk Low
2.21%Amplitude
--Gross Margin
0.00Market Cap
7.15Reward/Risk
3.54%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Telix Pharmaceuticals Ltd Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Buy
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
--/--
Revenue / Forecast
--/--
Relevant data have not been disclosed by the company yet.
Telix Pharmaceuticals Ltd Profile
Sector- -
Ticker SymbolTLX
Number of employees0
CountryAustralia
Ownership
| Shareholders | Proportion |
|---|---|
| Portland Investment Counsel Inc. | 0.08% |
| Lazard Asset Management, L.L.C. | 0.07% |
| Raiffeisen Bank International AG | 0.04% |
| Fidelity Management & Research Company LLC | 0.04% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 0.24% |
| Investment Advisor/Hedge Fund | 0.09% |
| Research Firm | 0.06% |
| Hedge Fund | 0.03% |
FAQs
What is the current price of Telix Pharmaceuticals Ltd (TLX)?
The current price of Telix Pharmaceuticals Ltd (TLX) is 11.95.
What is the symbol of Telix Pharmaceuticals Ltd?
The ticker symbol of Telix Pharmaceuticals Ltd is TLX.
What is the 52-week high of Telix Pharmaceuticals Ltd?
The 52-week high of Telix Pharmaceuticals Ltd is 13.11.
What is the 52-week low of Telix Pharmaceuticals Ltd?
The 52-week low of Telix Pharmaceuticals Ltd is 6.28.
Is Telix Pharmaceuticals Ltd (TLX) currently rated as Buy, Hold, or Sell?
According to analysts, Telix Pharmaceuticals Ltd (TLX) has an overall rating of STRONG BUY, with a price target of 19.95.